期刊文献+

RFA联合TACE治疗中晚期肝癌的疗效观察 被引量:9

THE FIRST AFFILIATED HOSPITAL OF BENGBU MEDICAL COLLEGE DEPARTMENT OF HEPATOBILIARY SURGERY
下载PDF
导出
摘要 目的观察射频消融术(RFA)联合导管动脉栓塞化疗(TACE)治疗晚期肝癌的临床效果。方法回顾性分析2005年6月~2011年6月蚌埠医学院第一附属医院肝胆外科92例接受TACE及RFA治疗的中晚期原发性肝癌患者,其中88例具有完整的临床治疗过程及随访资料,共43例接受TACE治疗(TACE组),45例接受TACE联合RFA治疗(TACE.RFA组),两组患者的一般临床资料及肿瘤情况差异无统计学意义,比较其生存状况并予以分层分析。结果手术前后螺旋CT摄片或彩超比较显示消融效果良好,两组治疗后肿瘤坏死总有效率(CR+PR)分别为67.4%(29/43)、91.1%(41/45),两组间差异有统计学意义(P<0.05)。接受RFA的患者与对照组相比其生存质量及生存时间均有显著提高。结论对于难以手术切除的原发性肝癌患者,RAF联合TACE的治疗效果明显优于单纯TACE。 Objective To observe the effect of radiofrequency catheter ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for advanced hepatocellular carcinoma clinical effect. Methods a retrospective analysis of 2005 June to 2011 June, the First Affiliated Hospital of Bengbu Medical College Department of hepatobiliary surgery 92 cases underwent TACE and RFA treatment in advanced primary liver cancer patients, including 88 cases with complete clinical treatment and follow - up data, a total of 43 patients treated with TACE (TACE group) ,45patients received TACE combined with RFA treatment (group TACE. RFA), two groups of patients with clinical data and tumor of the differences were not statistically significant, comparing their survival status and be stratified analysis. Results before and after the operation of spiral CT radiography or color comparison shows ablation effect is good, the two groups after the treatment of tumor necrosis rate (CR + PR) were 67.4% (29/43 ) ,91.1% (41/45 ), the difference between the two groups was statistically significant ( P 〈 0. 05). Patients undergoing RFA compared with the control group, the quality of life and survival time were significantly improved. Conclusions about the difficulty of operation resection of primary liver cancer pa- tients, RAF combined TACE treatment effect was better than that of pure TACE.
出处 《肝胆外科杂志》 2012年第5期362-366,共5页 Journal of Hepatobiliary Surgery
关键词 肝肿瘤 射频消融术 经导管动脉栓塞化疗 生存质量 生存期 liver tumor radiofrequeney ablation transcatheter arterial chemoembolization quality of life survival period
  • 相关文献

参考文献11

  • 1Jemal A. et al. Global cancer statistics,CA Cancer J Clin. 2011,61 (2) :69 -90.
  • 2Chen M S,Lj J Q, Ljang H H,et al. Comparison of effcts of Percutaneous radiofrequency ablation and surgical resction on small hepato- ceullular carcinoma. Zhonghua Yixue Zazhi,2005.85 (2) :80 - 83.
  • 3Lencioni R,Cioni D, Croetti L,et al. Early-stage hepato-cellular car- cinoma in patients with cirrhosis : long-term results of percutaneous image - guided radiofrequency ablation. Radiology, 2005,234 ( 3 ) : 961 - 967.
  • 4高恒军,梁惠宏,陈敏山,彭振维,张耀军,黎鹏,庞雄昊,张亚奇,李锦清.射频消融联合经导管肝动脉栓塞化疗治疗肝癌疗效分析[J].中华医学杂志,2008,88(36):2529-2532. 被引量:27
  • 5Liao G S, Yu C Y, Shih M L, et al. Radiofrequency ablation after transartcrial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol 2008 ; 34( 1 ) : 61 -66.
  • 6陈敏山,李锦清,梁惠宏,林小军,郭荣平,郑云,张亚奇.经皮射频消融与手术切除治疗小肝癌的疗效比较[J].中华医学杂志,2005,85(2):80-83. 被引量:144
  • 7Morrs D L, Horton M D, Dilley A V. et al. The treatment of hepatic metastasis by cryotherapy and regional eytotoxic perfusion. Gut, 1993, 34(9) :1156 - 1157.
  • 8倪雪君,周国雄,成建萍.射频消融治疗肝癌机制的研究进展[J].世界华人消化杂志,2008,16(30):3416-3420. 被引量:12
  • 9Vehri A, Moretto P, Doriguzzi A,et al. Radiofrequency thermal ablation(RFA) after transarterial chemoemblization(TACE) as combined therapy for unresectable non -early hepatocellular carcinoma( Hcc ). Eur Radio1,2006,16 (3) :661 - 669.
  • 10Sugimori K, Nozawa A, Morimdto M, et al. Extension of radiofrequency ablation of tile Iiver by transcatheter arterial embolization witll iodized oil and gelatin sponge:results in a pig model. J Vasc Interv Radio1,2005 ,16 :849 - 856.

二级参考文献39

共引文献203

同被引文献77

  • 1罗葆明,李高鹏.超声引导射频消融治疗肝癌的一些难点及其解决方案研究进展[J].中华医学超声杂志(电子版),2011,8(9):1893-1898. 被引量:5
  • 2游蓁,李宁.射频消融治疗肝脏肿瘤的临床研究[J].国际外科学杂志,2007,34(2):90-93. 被引量:4
  • 3林正理,蔡积武.肝癌少见的全身表现——旁癌综合征(附63例分析)[J].浙江实用医学,1997,2(2):45-47. 被引量:5
  • 4ShindohJ, HasegawaK, InoueY, IshizawaT, NagataR, et al. Risk factors of post-operative recurrence and adequate surgical approach to im- prove long-term outcomes of hepatocellular carcinoma. HPB ( Ox- ford) ,2013,15(1) :31 -9.
  • 5Casaccia M, Andorno E, Di Domenico S, et al. Laparoseopic resec- tion of hepatocellular carcinoma. Considerations on lesions in the pos- terosuperior segments of the liver. Ann Ital Chir,2012,83 (6) :503 - 8.
  • 6Germani G, Pleguezuelo M, Gurusamy K, et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injec- tion for hepatocelullar carcinoma: a meta-analysis. J Hepatol,2010, 52(3) :380 -8.
  • 7Kudo M, Ueshima K, Arizumi T. Real - life clinical practice with sorafenib in advanced hepatocellular carcinoma: a single-center expe- rience. Dig Dis,2012,30(6) :609 - 16.
  • 8Ndubula DA. Ojo OS. Adetiloye VA. et al. The incidence and characteristics of some paraneoplastic syndromes of hepatoce- llular carcinoma in Nigerian patients[J]. Eur J Gastroenterol Hepatol, 1999,11 (12) : 1401-1404.
  • 9Limin Wu ,Jiang Wu, Hongliang Zhang,et al. Hypoglycemia- induced convulsive status epilepticus as the initial presentation of primary hepatic caicinoma[J]. Neurol Sci,2012,33(6):1469- 1471.
  • 10Lau CI,Wang HC,Hsu WC,et al. Hypoglycemic encephalopathy as the initial presentation of hepatic tumor[J]. Neurologist, 2010,16(3) :206-207.

引证文献9

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部